Navigation Links
Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease


Animal Study Confirms Caprospinol's (SP-233) Ability to Clear Brain Plaque and Empower Rat Brain Cells to Recover Memory Function

In Vivo 'Proof of Concept' Study Proposes Direct Correlation Between Removing Beta Amyloid Plaque and Memory Recovery

LAS VEGAS, July 10, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in-vitro data and suggests Caprospinol may not only slow down Alzheimer's but may also reverse plaque-related brain injuries associated with the mind-robbing disease of Alzheimer's.

The hallmark of Alzheimer's disease is plaque formation in areas of the brain that control memory and thinking skills. Plaque can cause swelling and bumps on nerve cells, making it hard or even impossible for the cells to communicate. While the cause of Alzheimer's disease still remains unknown, a growing number of researchers are indicating that plaque formation and accumulation may play a role.

The study was conducted by Samaritan's collaborating researchers, including Dr. Laurent Lecanu and Dr. Vassilios Papadopoulos.

Abstract:

www.samaritanpharma.com/caprospinol_abstract.pdf

Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals stated, "Memory recovery in rats is a lot simpler than curing Alzheimer's disease in people but these study results are extremely encouraging. The rats tested with our proprietary Alzheimer's rat model took on features similar to the crippling dementia seen in a human's Alzheimer's brain, and then, by treating the
'"/>




Page: 1 2 3

Related medicine technology :

1. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
2. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
3. At the 2007 Alzheimers Association International Conference on the Prevention of Dementia - Neurochems U.S. Principal Investigator Presents Update on Tramiprosate (Alzhemed)
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:7/23/2008)... publication in July print edition of Clinical ...DIANAPOLIS, July 23 /- A Roche Diagno...N-terminal pro-B-type natriuretic peptide,(NT-proB...risk,stratification in predicting the risk of card...ted with non-steroidal anti-inflammatory drugs of,...
(Date:7/23/2008)...3 /- InCode BioPharmaceutics, Inc.,a...ced preclinical test,results demonstrating the uti...eatment of the rare chronic blood disorder paroxys...esults will be presented at the XXII,International...ber 28,2008., The only treatment currently avail...
(Date:7/22/2008).../- Nonin Medical, a leading innovator...an 20 years, has entered,the clinical testing phas...onal oxygen saturation. Today,s most common applic...ring of the regional blood oxygenation,in the brai...utcomes from an ongoing clinical study at the,Duke...
(Date:7/22/2008)... Lantus(R) and Apidra(R) Resulted in Significant, ..., Whatever the Algorithm ...ire/ -- Results from the "Adjust to,Target in Type...arbohydrate,Counting for Adjustment of Mealtime In...ican Diabetes Association,s (ADA) medical journal,...
Breaking Medicine Technology:Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Almost Family Announces Expansion of Revolving Credit Facility 7573 1Almost Family Announces Expansion of Revolving Credit Facility 7573 2Almost Family Announces Expansion of Revolving Credit Facility 7573 3Capital BlueCross HMO Plan is Ranked No 1 in Pennsylvania for Member Satisfaction 7571 1Capital BlueCross HMO Plan is Ranked No 1 in Pennsylvania for Member Satisfaction 7571 27 or 8 Hours of Sleep Best for Health 7569 1Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing 2067 1Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing 2067 2
...earch and Treatment of Rare but Devastating,Condit...ry University London,and the University of Leicest...ntial breakthrough in the treatment of a rare but,...dren and young,people. , In a world first, the cli...ave already treated one patient with promising,res...
...tner Forest Laboratories, Inc. Today,Announced the...cute,Ischemic Stroke) Study with the Compound Desm...N AG (Frankfurt Stock,Exchange, Prime Standard: PA...YSE: FRX) today announced topline results of,the D...y with the,compound Desmoteplase. The Phase III st...
Other Medicine Technology:World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
... saying that more family physicians are needed to ... University// of Utah School of Medicine and the U... needs of the population were increasing, so new h..."Family Physician Workforce Reform: Recommendation...
...pital have discovered that a protein called ABCB6 ...hat is key to the ability// of red blood cells to ... and of cells to extract energy from nutrients. T...ABCB6 is lodged within the outer membrane of the c...
...ublic health interventions can cost hundreds of li...n this week’s BMJ argue that, if the science is go...domised controlled trials are usually required bef... But in 2003, the BMJ published an article about t...
...stitute of MIT and Harvard announced today the dev...an connect human diseases// with potential drugs t...k in human cells. Called the 'Connectivity Map,' t...tember 29 issue of Science and in separate publica...
Other Medicine News:Health News:Call To Increase Family Physicians 2Health News:Call To Increase Family Physicians 3Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3
SUR-FIT Natura® Urostomy Pouch
New Image Urostomy Pouch, Beige
New Image Sterile Drainable Kits with Lock 'n Roll
New Image Pre-sized Flextend Skin Barrier, Floating Flange, with Tape
Medicine Products: